Join
Live feed
·
PRReleasevia Quantisnow
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases

ByQuantisnow·Wall Street's wire, on your screen.
CRDL· Cardiol Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRDL (Cardiol Therapeutics Inc.) and more on Quantisnow.